- Barclays lowered Vertex Pharmaceuticals Incorporated VRTX price target from $302 to $285. Vertex Pharmaceuticals shares fell 13.3% to $187.88 in pre-market trading.
- Roth Capital cut the price target on Ocugen, Inc. OCGN from $10 to $6. Ocugen shares rose 2.8% to $6.88 in pre-market trading.
- Wells Fargo raised Signet Jewelers Limited SIG price target from $57 to $70. Signet Jewelers shares rose 1.1% to $70.35 in pre-market trading.
- Rosenblatt reduced the price target on Snowflake Inc. SNOW from $270 to $265. Snowflake shares fell 3.5% to $240.00 in pre-market trading.
- Credit Suisse boosted Celsius Holdings, Inc. CELH price target from $57 to $78. Celsius Holdings shares rose 2.8% to $63.50 in pre-market trading.
- Goldman Sachs raised the price target on Canadian Natural Resources Limited CNQ from $38 to $44. Canadian Natural Resources shares fell 0.2% to close at $36.97 on Thursday.
- RBC Capital lifted the price target for Prothena Corporation plc PRTA from $28 to $50. Prothena shares fell 1.2% to $44.00 in pre-market trading.
- JP Morgan cut MorphoSys AG MOR price target from $32 to $24. MorphoSys shares fell 4.3% to $20.58 in pre-market trading.
- B of A Securities boosted the price target for Embraer S.A. ERJ from $8 to $20. Embraer shares rose 4.3% to $16.40 in pre-market trading.
- Raymond James boosted FS Bancorp, Inc. FSBW price target from $72 to $77. FS Bancorp shares fell 2.3% to close at $69.48 on Thursday.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in